Delivra Health Brands CEO discusses sales gains, new products and global push - ICYMI

Delivra Health Brands Inc. (TSX-V:DHB) CEO Gord Davey joined Proactive to discuss the company’s latest financial and operational results, reporting a 3% year-over-year revenue increase.

Davey emphasized that the steady performance reflects a consistent growth strategy focused on account acquisition, expanded product offerings, and geographic reach.

Proactive: All right, welcome back inside our Proactive newsroom. And joining me now is Gord Davey. He is the CEO of Delivra Health Brands. And Gord, good to see you again. How are you?

Gord Davey: Hey, as always, it's great to see you. I'm doing great.

Good stuff. Well, I know that you've released your financial and operational results for the last 3 to 9 months, and again showing a 3% year-over-year revenue increase. And really, I would say, steady numbers. Is that fair to say, Gord?

Yeah, I think that's exactly what it is. We've been very consistent with our strategic planning over the past years, and that strategy has been around adding new accounts, selling more products to those new accounts and adding more territories. And with that strategy, we have really continued to grow quarter after quarter, year over year. So the strategy is working and our growth is happening.

What sort of has been leading this? Can you sort of talk about what the successes you're seeing?

Yeah, I think that there's a number of things. We've added several new accounts, not only in North America but globally as well. So that addition to new accounts – and that's in the thousands – we've added thousands of new accounts. But we've also added in new innovation to the current accounts as well, adding in our Dream Water sleep gummies, both in a 60 count and a 6 count, as well as we've added in Dream Water Immunity. We've also really established a route to market with our LivRelief brand. And with that route to market, adding in more programs and customer-specific programs, we've been able to increase the amount of units that we've done year over year in our LivRelief brand. So a combination of both of those things, has really added to the top line as well as the bottom line.

Gord, I know you've reinvested within the company and a new digital marketing campaign – a couple of them – that have shown some success. Can you sort of talk about that aspect of it?

I sure can. Again, this is part of our strategy. We've been able to overindex our spend this year in our marketing and awareness programs, and we've added in two national campaigns: one for LivRelief, and that is "Quiet Your Chronic Pain," and then we ordered one in for Dream Water as well, "Shush Your Mind." With this overinvestment, it has allowed us to add more viewers and more people touching our brands. We realized that we were overindexed, but even in our third quarter, spending more money on marketing and advertising, we're still in a positive EBITDA position. So we'll continue to invest into those programs, continue to drive people towards our brands and continue to make sure they're more aware of the programs we have happening.

And lastly, Gord, you'll continue with the global reach of the company. I know you've had successes overseas as well. That's going to continue?

Absolutely. We just did an interview just a couple of days ago with the extension of growing our product in the Middle East, in Kuwait, and adding in new products over there – our 60-count gummies. And that will continue. That will continue on with our new innovation, but also in new territories as well.

Quotes have been lightly edited for clarity and style